(RTTNews) - RedHill Biopharma (RDHL) Tuesday announced that it has launched a Phase 2 trial to assess opaganib's ability to enhance darolutamide in treating metastatic castrate-resistant prostate ...
Arkansas' first noninvasive treatment of early-stage prostate cancer was successfully performed at St. Bernards Medical Center, reducing risks and side effects.
Distant-stage prostate cancer increased and mortality rates plateaued throughout California during the 2010s, accordin ...
The 80-patient placebo-controlled randomized Phase 2 study will evaluate the efficacy of opaganib in combination with Bayer's darolutamide in men with metastatic castrate-resistant ...
RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced ...
Northwell Staten Island University Hospital has announced the addition of the Focal One High-Intensity Focused Ultrasound ...
Researchers at Vanderbilt and the University of Michigan have shown that a simple at-home urine test for prostate cancerscreeningis highly accurate. The exciting new results, published in The Journal ...
Key takeawaysThe researchers found patients with moderate or worse early side effects were more likely to experience severe late effects, even years ...
Radiotherapy, a standard of care treatment for localized prostate cancer includes, has shown remarkable success. This ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback